SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008581
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:05
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220512x8k.htm   iXBRL 8-K 37994
2 EX-99.1 tmb-20220512xex99d1.htm EX-99.1 144295
3 GRAPHIC tmb-20220512xex99d1001.jpg GRAPHIC 8436
  Complete submission text file 0001558370-22-008581.txt   328206

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220512.xsd EX-101.SCH 3061
5 EX-101.LAB tmb-20220512_lab.xml EX-101.LAB 16019
6 EX-101.PRE tmb-20220512_pre.xml EX-101.PRE 10426
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220512x8k_htm.xml XML 4854
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 22918349
SIC: 2834 Pharmaceutical Preparations